Browse > Article
http://dx.doi.org/10.3350/cmh.2013.19.2.185

${\beta}$-catenin activated hepatocellular adenoma  

Chu, Hyun Hee (Department of Pathology and Research Institute for Endocrine Science, Chonbuk National University Medical School)
Moon, Woo Sung (Department of Pathology and Research Institute for Endocrine Science, Chonbuk National University Medical School)
Publication Information
Clinical and Molecular Hepatology / v.19, no.2, 2013 , pp. 185-189 More about this Journal
Keywords
Hepatocellular adenoma; ${\beta}$-catenin activated; Hepatocelluar carcinoma;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bioulac-Sage P, Balabaud C, Wanless I. Focal nodular hyperplasia and hepatocellular adenoma. In: Bosman F, Carneiro F, Hruban R, Theise ND, eds. WHO Classification of Tumours of the Digestive System, 4th Ed. Lyon, France: IARC Press, 2010:198-204.
2 Velazquez I, Alter BP. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 2004;77:257-267.   DOI
3 Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740-748.   DOI
4 Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006;43:515-524.   DOI
5 Bioulac-Sage P, Cubel G, Balabaud C. Pathological diagnosis of hepatocellular adenoma in clinical practice. Diagnostic Histopathology 2011;17:521-529.   DOI
6 Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009;50:481-489.   DOI
7 Micchelli ST, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M. Malignant transformation of hepatic adenomas. Mod Pathol 2008;21:491-497.   DOI
8 van Aalten SM, Verheij J, Terkivatan T, Dwarkasing RS, de Man RA, Ijzermans JN. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol 2011;55:120-125.   DOI
9 Van der Borght S, Libbrecht L, Katoonizadeh A, Aerts R, Nevens F, Verslype C, et al. Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy. Histopathology 2007;51:855-856.   DOI
10 Bioulac-Sage P, Cubel G, Balabaud C, Zucman-Rossi J. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis 2011;31:91-103.   DOI
11 Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008;48:808-818.   DOI